Literature DB >> 22084313

Functional CSF-1 receptors are located at the nuclear envelope and activated via the p110δ isoform of PI 3-kinase.

Olivier Zwaenepoel1, Niki Tzenaki, Aikaterini Vergetaki, Antonis Makrigiannakis, Bart Vanhaesebroeck, Evangelia A Papakonstanti.   

Abstract

Colony stimulating factor-1 (CSF-1) and its receptor (CSF-1R) are key regulators of macrophage biology, and their elevated expression in cancer cells has been linked to poor prognosis. CSF-1Rs are thought to function at the plasma membrane. We show here that functional CSF-1Rs are present at the nuclear envelope of various cell types, including primary macrophages, human cancer cell lines, and primary human carcinomas. In response to CSF-1, added to intact cells or isolated nuclei, nucleus-associated CSF-1R became phosphorylated and triggered the phosphorylation of Akt and p27 inside the nucleus. Extracellularly added CSF-1 was also found to colocalize with nucleus-associated CSF-1Rs. All these activities were found to depend selectively on the activity of the p110δ isoform of phosphoinositide 3-kinase (PI3K). This finding was related to the p110δ-dependent translocation of exogenous CSF-1 to the nucleus-associated CSF-1Rs, correlating with a prominent role of p110δ in activation of the Rab5 GTPase, a key regulator of the endocytic trafficking. siRNA-silencing of Rab5a phenocopied p110δ inactivation and nuclear CSF-1 signaling. Our work demonstrates for the first time the presence of functional nucleus-associated CSF-1Rs, which are activated by extracellular CSF-1 by a mechanism that involves p110δ and Rab5 activity. These findings may have important implications in cancer development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22084313     DOI: 10.1096/fj.11-189753

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  8 in total

Review 1.  Endocytic trafficking of chemokine receptors.

Authors:  Adriano Marchese
Journal:  Curr Opin Cell Biol       Date:  2013-12-14       Impact factor: 8.382

Review 2.  Phosphatidylinositol-3,4,5-trisphosphate: tool of choice for class I PI 3-kinases.

Authors:  Rachel Schnur Salamon; Jonathan M Backer
Journal:  Bioessays       Date:  2013-07       Impact factor: 4.345

3.  Possible mechanisms and function of nuclear trafficking of the colony-stimulating factor-1 receptor.

Authors:  Elisabetta Rovida; Persio Dello Sbarba
Journal:  Cell Mol Life Sci       Date:  2014-06-28       Impact factor: 9.261

4.  Amelioration of cancer stem cells in macrophage colony stimulating factor-expressing U87MG-human glioblastoma upon 5-fluorouracil therapy.

Authors:  S Chockalingam; Siddhartha Sankar Ghosh
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

5.  Dynamic gene regulation by nuclear colony-stimulating factor 1 receptor in human monocytes and macrophages.

Authors:  Laura Bencheikh; M'Boyba Khadija Diop; Julie Rivière; Aygun Imanci; Gerard Pierron; Sylvie Souquere; Audrey Naimo; Margot Morabito; Michaël Dussiot; Frédéric De Leeuw; Camille Lobry; Eric Solary; Nathalie Droin
Journal:  Nat Commun       Date:  2019-04-26       Impact factor: 14.919

6.  p110δ PI3 kinase pathway: emerging roles in cancer.

Authors:  Niki Tzenaki; Evangelia A Papakonstanti
Journal:  Front Oncol       Date:  2013-03-01       Impact factor: 6.244

7.  Vinculin and Rab5 complex is required [correction of requited]for uptake of Staphylococcus aureus and interleukin-6 expression.

Authors:  Makoto Hagiwara; Eitoyo Kokubu; Shinsuke Sugiura; Toshinori Komatsu; Hiroyuki Tada; Ryutaro Isoda; Naomi Tanigawa; Yoshiko Kato; Naoyuki Ishida; Kaoru Kobayashi; Misako Nakashima; Kazuyuki Ishihara; Kenji Matsushita
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

8.  Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells.

Authors:  V Barbetti; A Morandi; I Tusa; G Digiacomo; M Riverso; I Marzi; M G Cipolleschi; S Bessi; A Giannini; A Di Leo; P Dello Sbarba; E Rovida
Journal:  Oncogene       Date:  2013-12-23       Impact factor: 9.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.